CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
|
Total |
Series A, Preferred Stock |
Series B, Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Stock Payable [Member] |
Retained Earnings (Accumulated Deficit) |
Noncontrolling Interest |
Balance, shares at Mar. 31, 2020 |
|
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
$ (2,937,780)
|
$ 500
|
$ 0
|
$ 37,975
|
$ 43,533,243
|
$ 0
|
$ (46,427,396)
|
$ (82,101)
|
Issuance of common stock upon conversion, shares |
|
|
|
37,926,239
|
|
|
|
|
Issuance of common stock upon conversion, amount |
226,437
|
|
|
$ 3,793
|
222,644
|
|
|
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures |
205,000
|
|
|
|
205,000
|
|
|
|
Purchase of Series B Preferred shares, shares |
|
|
1,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
1,250,000
|
|
$ 0
|
|
1,250,000
|
|
|
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
|
|
293,000
|
|
(293,000)
|
|
Dividends payable on Series B PS |
(144,792)
|
|
|
|
|
|
(144,792)
|
|
Series B PS Dividends in kind issued, shares |
|
|
50
|
|
|
|
|
|
Series B PS Dividends in kind issued, amount |
56,458
|
|
$ 0
|
|
56,458
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(800)
|
33,569,730
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ (0)
|
$ 3,357
|
(3,357)
|
|
|
|
Common stock issued in Vista Warrant settlement, shares |
|
|
|
17,500,000
|
|
|
|
|
Common stock issued in Vista Warrant settlement, amount |
610,000
|
|
|
$ 1,750
|
608,250
|
|
|
|
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement |
90,000
|
|
|
|
90,000
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
1,250,000
|
|
|
|
|
Common stock issued to consultant, amount |
61,250
|
|
|
$ 125
|
61,125
|
|
|
|
Net loss |
(478,967)
|
|
|
|
|
|
(477,072)
|
(1,895)
|
Balance, shares at Jun. 30, 2020 |
|
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(1,062,394)
|
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
Balance, shares at Mar. 31, 2020 |
|
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(2,937,780)
|
$ 500
|
$ 0
|
$ 37,975
|
43,533,243
|
0
|
(46,427,396)
|
(82,101)
|
Common stock issued to consultant, amount |
745,250
|
|
|
|
|
|
|
|
Net loss |
(1,678,684)
|
|
|
|
|
|
|
|
Balance, shares at Dec. 31, 2020 |
|
5,000,000
|
1,920
|
544,989,181
|
|
|
|
|
Balance, amount at Dec. 31, 2020 |
5,579,607
|
$ 500
|
$ 0
|
$ 54,500
|
55,437,431
|
135,775
|
(49,961,843)
|
(86,756)
|
Balance, shares at Jun. 30, 2020 |
|
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(1,062,394)
|
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
Issuance of common stock upon conversion, shares |
|
|
|
1,014,001
|
|
|
|
|
Issuance of common stock upon conversion, amount |
125,736
|
|
|
$ 101
|
125,635
|
|
|
|
Purchase of Series B Preferred shares, shares |
|
|
1,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
1,250,000
|
|
$ 0
|
|
1,250,000
|
|
|
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
$ 0
|
|
807,000
|
|
(807,000)
|
|
Dividends payable on Series B PS |
(83,960)
|
|
|
|
|
|
(83,960)
|
|
Series B PS Dividends in kind issued, shares |
|
|
65
|
|
|
|
|
|
Series B PS Dividends in kind issued, amount |
77,984
|
|
|
|
77,984
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(2,369)
|
58,521,249
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ (0)
|
$ 5,852
|
(5,852)
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
1,500,000
|
|
|
|
|
Common stock issued to consultant, amount |
67,500
|
|
|
$ 150
|
67,350
|
|
|
|
Net loss |
(589,879)
|
|
|
|
|
|
(588,193)
|
(1,686)
|
Balance, shares at Sep. 30, 2020 |
|
5,000,000
|
1,696
|
531,023,743
|
|
|
|
|
Balance, amount at Sep. 30, 2020 |
(215,012)
|
$ 500
|
$ (0)
|
$ 53,103
|
48,638,480
|
0
|
(48,821,413)
|
(85,682)
|
Issuance of common stock upon conversion, shares |
|
|
|
795,387
|
|
|
|
|
Issuance of common stock upon conversion, amount |
198,848
|
|
|
$ 80
|
198,768
|
|
|
|
Purchase of Series B Preferred shares, shares |
|
|
750
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
750,000
|
|
$ 0
|
|
750,000
|
|
|
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
|
|
235,000
|
|
(235,000)
|
|
Common stock issued to consultant, shares |
|
|
|
1,500,000
|
|
|
|
|
Common stock issued to consultant, amount |
616,500
|
|
|
$ 150
|
616,350
|
|
|
|
Net loss |
(609,838)
|
|
|
|
|
|
(608,764)
|
(1,074)
|
Dividends payable on Series B Preferred Shares |
(88,333)
|
|
|
|
|
|
(88,333)
|
|
Conversion of Series B Preferred Shares to common stock, shares |
|
|
(526)
|
5,670,051
|
|
|
|
|
Conversion of Series B Preferred Shares to common stock, amount |
0
|
|
$ 0
|
$ 567
|
(567)
|
|
|
|
Beneficial conversion feature related to the Series D Preferred Shares |
5,000,000
|
|
|
|
5,000,000
|
|
|
|
Amortization of beneficial conversion feature related to Series D Preferred Shares |
(208,333)
|
|
|
|
|
|
(208,333)
|
|
Commitment shares issued with Series D Preferred Shares, shares |
|
|
|
6,000,000
|
|
|
|
|
Commitment shares issued with Series D Preferred Shares, amount |
0
|
|
|
$ 600
|
(600)
|
|
|
|
Common stock to be issued as finder's fees related to asset acquisition |
135,775
|
|
|
|
|
135,775
|
|
|
Balance, shares at Dec. 31, 2020 |
|
5,000,000
|
1,920
|
544,989,181
|
|
|
|
|
Balance, amount at Dec. 31, 2020 |
5,579,607
|
$ 500
|
$ 0
|
$ 54,500
|
55,437,431
|
135,775
|
(49,961,843)
|
(86,756)
|
Balance, shares at Mar. 31, 2021 |
|
5,000,000
|
607
|
560,745,180
|
|
|
|
|
Balance, amount at Mar. 31, 2021 |
3,070,968
|
$ 500
|
$ 0
|
$ 56,076
|
56,649,491
|
136,000
|
(53,683,268)
|
(87,830)
|
Issuance of common stock upon conversion, shares |
|
|
|
1,329,246
|
|
|
|
|
Issuance of common stock upon conversion, amount |
421,486
|
|
|
$ 133
|
421,353
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(262)
|
3,144,000
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ 0
|
$ 314
|
(314)
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
125,000
|
|
|
|
|
Common stock issued to consultant, amount |
73,651
|
|
|
$ 13
|
48,738
|
24,900
|
|
|
Net loss |
(2,562,743)
|
|
|
|
|
|
(2,562,743)
|
|
Conversion of Series D PS to common stock, shares |
|
|
|
428,572
|
|
|
|
|
Conversion of Series D PS to common stock, amount |
0
|
|
$ 0
|
$ 43
|
(43)
|
|
|
|
Exchange of Series D PS to Series E PS |
(3,258,189)
|
|
|
|
|
|
(3,258,189)
|
|
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares |
|
|
|
35,772,729
|
|
|
|
|
Sale of common shares and warrants for cash, less offering costs and commitment shares, amount |
17,277,123
|
|
|
$ 3,577
|
17,273,546
|
|
|
|
Exercise of warrants related to the sale of common shares, shares |
|
|
|
1,100,000
|
|
|
|
|
Exercise of warrants related to the sale of common shares, amount |
11,000
|
|
|
$ 110
|
10,890
|
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
3,269,505
|
|
|
|
3,269,505
|
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
(817,376)
|
|
|
|
|
|
(817,376)
|
|
Redemption of Series D Preferred shares |
(2,534,758)
|
|
|
|
|
|
(2,534,758)
|
|
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity |
(1,000,000)
|
|
|
|
(3,087,830)
|
2,000,000
|
|
87,830
|
Common shares to be issued for Patent acquisition |
5,000,000
|
|
|
|
|
5,000,000
|
|
|
Balance, shares at Jun. 30, 2021 |
|
5,000,000
|
345
|
602,644,727
|
|
|
|
|
Balance, amount at Jun. 30, 2021 |
18,950,668
|
$ 500
|
$ 0
|
$ 60,266
|
74,585,336
|
7,160,900
|
(62,856,334)
|
0
|
Balance, shares at Mar. 31, 2021 |
|
5,000,000
|
607
|
560,745,180
|
|
|
|
|
Balance, amount at Mar. 31, 2021 |
3,070,968
|
$ 500
|
$ 0
|
$ 56,076
|
56,649,491
|
136,000
|
(53,683,268)
|
(87,830)
|
Common stock issued to consultant, amount |
398,831
|
|
|
|
|
|
|
|
Net loss |
(38,778,923)
|
|
|
|
|
|
|
|
Balance, shares at Dec. 31, 2021 |
|
5,000,000
|
67
|
641,722,043
|
|
|
|
|
Balance, amount at Dec. 31, 2021 |
14,598,300
|
$ 500
|
$ 0
|
$ 64,183
|
86,808,591
|
29,524,000
|
(101,798,974)
|
0
|
Balance, shares at Jun. 30, 2021 |
|
5,000,000
|
345
|
602,644,727
|
|
|
|
|
Balance, amount at Jun. 30, 2021 |
18,950,668
|
$ 500
|
$ 0
|
$ 60,266
|
74,585,336
|
7,160,900
|
(62,856,334)
|
0
|
Common stock issued to consultant, shares |
|
|
|
62,500
|
|
|
|
|
Common stock issued to consultant, amount |
49,275
|
|
|
$ 6
|
24,369
|
24,900
|
|
|
Net loss |
(2,849,635)
|
|
|
|
|
|
(2,849,635)
|
|
Dividends payable on Series B Preferred Shares |
|
|
|
|
|
|
(182,639)
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
(1,341,948)
|
|
|
|
|
|
(1,341,948)
|
|
Conversion of Series E PS to common stock, shares |
|
|
|
4,114,286
|
|
|
|
|
Conversion of Series E PS to common stock, amount |
0
|
|
|
$ 411
|
(411)
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(177,586)
|
|
Common shares to be issued for Technical and Equipment Rights Agreement |
4,762,376
|
|
|
|
|
4,762,376
|
|
|
Balance, shares at Sep. 30, 2021 |
|
5,000,000
|
345
|
606,821,513
|
|
|
|
|
Balance, amount at Sep. 30, 2021 |
19,210,511
|
$ 500
|
$ 0
|
$ 60,683
|
74,609,294
|
11,948,176
|
(67,408,142)
|
0
|
Conversion of Series B PS to common stock, shares |
|
|
(278)
|
3,336,000
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
(334)
|
|
|
$ 334
|
(334)
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
112,500
|
|
|
|
|
Common stock issued to consultant, amount |
49,275
|
|
|
$ 21
|
99,054
|
(49,800)
|
|
|
Net loss |
(33,366,545)
|
|
|
|
|
|
(33,366,545)
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
169,714
|
|
|
0
|
169,714
|
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
(831,543)
|
|
|
$ 0
|
0
|
|
(831,543)
|
|
Conversion of Series E PS to common stock, shares |
|
|
|
4,114,286
|
|
|
|
|
Conversion of Series E PS to common stock, amount |
2,879,589
|
|
|
$ 411
|
2,879,589
|
|
|
|
Dividends payable on Preferred Shares |
(112,577)
|
|
|
0
|
0
|
|
(112,577)
|
|
Accretion of Series E Preferred Shares |
(80,167)
|
|
|
$ 0
|
0
|
|
(80,167)
|
|
Common shares issued for Technical and Equipment Rights Agreement, shares |
|
|
|
26,732,673
|
|
|
|
|
Common shares issued for Technical and Equipment Rights Agreement, amount |
0
|
|
|
$ 2,673
|
11,759,703
|
(11,762,376)
|
|
|
Common stock issued to consultants, shares |
|
|
|
430,071
|
|
|
|
|
Common stock issued to consultants, amount |
158,328
|
|
|
$ 43
|
158,285
|
|
|
|
Common stock issued to employees, shares |
|
|
|
175,000
|
|
|
|
|
Common stock issued to employees, amount |
68,304
|
|
|
$ 18
|
68,286
|
|
|
|
Reclassification of warrants to liability |
(2,935,000)
|
|
|
|
(2,935,000)
|
|
|
|
Common stock to be issued for legal settlement to NSH shareholders |
29,388,000
|
|
|
|
|
29,388,000
|
|
|
Balance, shares at Dec. 31, 2021 |
|
5,000,000
|
67
|
641,722,043
|
|
|
|
|
Balance, amount at Dec. 31, 2021 |
$ 14,598,300
|
$ 500
|
$ 0
|
$ 64,183
|
$ 86,808,591
|
$ 29,524,000
|
$ (101,798,974)
|
$ 0
|